0576-88813233
产品描述:
MRE-269(ACT-333679)是前列腺素I2受体(prostaglandin I2 receptor)激动剂,对人源前列腺素I2受体的结合亲和力是对其他人源前列腺素受体的130倍。
中文别名:
SELEXIPAG中间体; 赛乐西帕中间体3; 赛乐西帕中间体; [4-[(5,6-二苯基吡嗪基)
物化属性:
密度:1.160
[1]. Fuchikami C, et al. A comparison of vasodilation mode among selexipag (NS-304; [2-{4-[(5,6-diphenylpyrazin-2-yl)(isopropyl)amino]butoxy}-N-(methylsulfonyl)acetamide]), its active metabolite MRE-269 and various prostacyclin receptor agonists in rat, porcin
[2]. Orie NN, et al. Differential actions of the prostacyclin analogues treprostinil and iloprost and the selexipag metabolite, MRE-269 (ACT-333679) in rat small pulmonary arteries and veins. Prostaglandins Other Lipid Mediat. 2013 Oct;106:1-7
版权所有 Copyright(C) 2018-2022 台州市科瑞生物技术有限公司